Alcohol-induced modulation of signaling pathways in liver parenchymal and nonparenchymal cells: Implications for immunity

Seminars in Liver Disease

Volumn 29, Issue 2, 2009, Pages 166-177

  Nath, Bharath ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Ethanol; Hepatitis; Inflammation; Steatosis; Toll like receptors

Indexed keywords

ADIPONECTIN; ALCOHOL; CYCLIC AMP; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; AUTOIMMUNITY; FATTY LIVER; HEPATITIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; IMMUNE DYSREGULATION; INNATE IMMUNITY; KUPFFER CELL; LIPID LIVER LEVEL; LIPID STORAGE; LIVER CELL; LIVER INJURY; LIVER NECROSIS; LIVER PARENCHYMA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TISSUE REACTION; VIRUS IMMUNITY;

ALCOHOL DRINKING; ANIMALS; AUTOIMMUNITY; ETHANOL; FATTY LIVER, ALCOHOLIC; HEPATOCYTES; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; KUPFFER CELLS; LIPID METABOLISM; LIVER; LIVER DISEASES, ALCOHOLIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 67649980706     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0029-1214372     Document Type: Review

References (118)

1. Sozio M, Crabb DW. Alcohol and lipid metabolism. Am J Physiol Endocrinol Metab 2008;295:E10-E16
2. Yin HQ, Kim M, Kim JH, et al. Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice. Toxicol Appl Pharmacol 2007;223:225-233 (Pubitemid 47371140)
3. Klassen LW, Thiele GM, Duryee MJ, et al. An in vitro method of alcoholic liver injury using precision-cut liver slices from rats. Biochem Pharmacol 2008;76:426-436
4. Bensinger SJ, Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 2008;454:470-477; Review
5. Wan YJ, Morimoto M, Thurman RG, Bojes HK, French SW. Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease. Life Sci 1995;56:307-317 (Pubitemid 124014539)
6. Fischer M, You M, Matsumoto M, Crabb DW. Peroxisome proliferator- activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem 2003;278:27997-28004 (Pubitemid 36899995)
7. Nanji AA, Dannenberg AJ, Jokelainen K, Bass NM. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)- regulated genes and is ameliorated by PPARalpha activation. J Pharmacol Exp Ther 2004;310:417-424 (Pubitemid 38812737)
8. Nakajima T, Kamijo Y, Tanaka N, et al. Peroxisome proliferator-activated receptor alpha protects against alcohol- induced liver damage. Hepatology 2004;40:972-980 (Pubitemid 39288131)
9. Gyamfi MA, He L, French SW, Damjanov I, Wan YJ. Hepatocyte retinoid X receptor alpha-dependent regulation of lipid homeostasis and inflammatory cytokine expression contributes to alcohol-induced liver injury. J Pharmacol Exp Ther 2008;324:443-453 (Pubitemid 351185853)
10. Nakamachi T, Nomiyama T, Gizard F, et al. PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes. Diabetes 2007;56:1662-1670 (Pubitemid 46842601)
11. Lee JH, Banerjee A, Ueno Y, Ramaiah SK. Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor {alpha} expression following ethanol-associated hepatic injury in vivo and in vitro. Toxicol Sci 2008;106:290-299
12. Chen X, Sebastian BM, Nagy LE. Chronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytes. Am J Physiol Endocrinol Metab 2007;292: E621-E628 (Pubitemid 46220588)
13. You M, Considine RV, Leone TC, Kelly DP, Crabb DW. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 2005;42:568-577 (Pubitemid 41233649)
14. Beraza N, Malato Y, Vander Borght S, et al. Pharmacological IkK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis. Gut 2008;57:655-663 (Pubitemid 351579980)
15. Rogers CQ, Ajmo JM, You M. Adiponectin and alcoholic fatty liver disease. IUBMB Life 2008;60:790-797
16. Tomita K, Tamiya G, Ando S, et al. AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats. Alcohol Clin Exp Res 2005;29(12, Suppl):240S-245S (Pubitemid 43053677)
17. Bergheim I, Guo L, Davis MA, et al. Metformin prevents alcohol-induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1. Gastroenterology 2006; 130:2099-2112 (Pubitemid 43816952)
18. Ye P, He YL, Wang Q, Liu YX. The alteration of plasminogen activator inhibitor-1 expression by linoleic acid and fenofibrate in HepG2 cells. Blood Coagul Fibrinolysis 2007;18:15-19 (Pubitemid 46006268)
19. Diluzio NR, Costales F. Inhibition of the ethanol and carbon tetrachloride induced fatty liver by antioxidants. Exp Mol Pathol 1965;28:141-154
20. Kono H, Rusyn I, Yin M, et al. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 2000;106:867-872 (Pubitemid 30750396)
21. Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 2008;44:723-738
22. Koop DR, Tierney DJ. Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. Bioessays 1990;12:429-435; Review
23. Lu Y, Zhuge J, Wang X, Bai J, Cederbaum AI. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology 2008;47:1483-1494 (Pubitemid 351702732)
24. Kono H, Bradford BU, Yin M, et al. CYP2E1 is not involved in early alcohol-induced liver injury. Am J Physiol 1999;277(6 Pt 1):G1259-G1267 (Pubitemid 30046029)
25. Wan YY, Cai Y, Li J, et al. Regulation of peroxisome proliferator activated receptor alpha-mediated pathways in alcohol fed cytochrome P450 2E1 deficient mice. Hepatol Res 2001;19:117-130 (Pubitemid 32097937)
26. Ohata M, Suzuki H, Sakamoto K, et al. Pioglitazone prevents acute liver injury induced by ethanol and lipopolysaccharide through the suppression of tumor necrosis factor-alpha. Alcohol Clin Exp Res 2004;28(suppl):139S-144S (Pubitemid 44139576)
27. Enomoto N, Takei Y, Hirose M, et al. Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-gamma, pioglitazone. J Pharmacol Exp Ther 2003;306:846-854 (Pubitemid 37025289)
28. Tomita K, Azuma T, Kitamura N, et al. Pioglitazone prevents alcohol-induced fatty liver in rats through upregulation of c-Met. Gastroenterology 2004;126:873-885 (Pubitemid 38298335)
29. Mitra SK, Varma SR, Godavarthi A, Nandakumar KS. Liv.52 regulates ethanol induced PPARgamma and TNF alpha expression in HepG2 cells. Mol Cell Biochem 2008; 315:9-15
30. Lieber CS, Leo MA, Wang X, Decarli LM. Effect of chronic alcohol consumption on hepatic SIRT1 and PGC- 1alpha in rats. Biochem Biophys Res Commun 2008;370: 44-48
31. Qin X, Xie X, Fan Y, et al. Peroxisome proliferatoractivated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice. Hepatology 2008;48:432-441
32. You M, Liang X, Ajmo JM, Ness GC. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am J Physiol Gastrointest Liver Physiol 2008;294:G892-G898
33. Ajmo JM, Liang X, Rogers CQ, Pennock B, You M. Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 2008;295:G833-G842
34. Oliva J, French BA, Li J, Bardag-Gorce F, Fu P, French SW. Sirt1 is involved in energy metabolism: the role of chronic ethanol feeding and resveratrol. Exp Mol Pathol 2008;85:155-159
35. You M, Fischer M, Deeg MA, Crabb DW. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 2002;277:29342-29347
36. Ji C, Chan C, Kaplowitz N. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J Hepatol 2006;45:717-724 (Pubitemid 44479875)
37. Horiguchi N, Wang L, Mukhopadhyay P, et al. Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 2008;134:1148-1158
38. Hebbachi AM, Knight BL, Wiggins D, Patel DD, Gibbons GF. Peroxisome proliferator-activated receptor alpha deficiency abolishes the response of lipogenic gene expression to re-feeding: restoration of the normal response by activation of liver X receptor alpha. J Biol Chem 2008; 283:4866-4876
39. Yoshikawa T, Ide T, Shimano H, et al. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling. Mol Endocrinol 2003;17:1240-1254
40. Bykov I, Junnikkala S, Pekna M, Lindros KO, Meri S. Complement C3 contributes to ethanol-induced liver steatosis in mice. Ann Med 2006;38:280-286 (Pubitemid 43862330)
41. Pritchard MT, McMullen MR, Stavitsky AB, et al. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 2007;132:1117-1126
42. Thakur V, McMullen MR, Pritchard MT, Nagy LE. Regulation of macrophage activation in alcoholic liver disease. J Gastroenterol Hepatol 2007;22(Suppl 1):S53-S56 (Pubitemid 46848991)
43. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008;48:322-335 (Pubitemid 351975556)
44. YinM,Wheeler MD, Kono H, et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999;117:942-952 (Pubitemid 29468238)
45. Bjarnason I, Peters TJ,Wise RJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984; 1(8370):179-182 (Pubitemid 14221988)
46. Nanji AA, Khettry U, Sadrzadeh SM, Yamanaka T. Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol 1993;142:367-373 (Pubitemid 23057448)
47. Tang Y, Banan A, Forsyth CB, et al. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res 2008;32:355-364
48. Lencer WI. Patching a leaky intestine. N Engl J Med 2008; 359:526-568
49. JinW,Wang H, Ji Y, et al. Increased intestinal inflammatory response and gut barrier dysfunction in Nrf2-deficient mice after traumatic brain injury. Cytokine 2008;44:135-140
50. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine 2008;42:145-151
51. Lukkari TA, Järveläinen HA, Oinonen T, Kettunen E, Lindros KO. Short-term ethanol exposure increases the expression of Kupffer cell CD14 receptor and lipopolysaccharide binding protein in rat liver. Alcohol Alcohol 1999;34:311-319 (Pubitemid 29295158)
52. Romics L, Mandrekar P, Kodys K, et al. Increased lipopolysaccharide sensitivity in alcoholic fatty livers is independent of leptin deficiency and toll-like receptor 4 (TLR4) or TLR2 mRNA expression. Alcohol Clin Exp Res 2005;29:1018-1026 (Pubitemid 40934206)
53. Gustot T, Lemmers A, Moreno C, et al. Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 2006;43:989 (Pubitemid 43724624)
54. Yin M, Bradford BU, Wheeler MD, et al. Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol 2001;166:4737-4742 (Pubitemid 32233762)
55. Uesugi T, Froh M, Arteel GE, et al. Role of lipopolysaccharide- binding protein in early alcohol-induced liver injury in mice. J Immunol 2002;168:2963-2969 (Pubitemid 34211677)
56. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004;16:3-9
57. Vogel SN, Fitzgerald KA, Fenton MJ. TLRs: differential adapter utilization by toll-like receptors mediates TLRspecific patterns of gene expression. Mol Interv 2003;3:466-477
58. Severa M, Fitzgerald KA. TLR-mediated activation of type I IFN during antiviral immune responses: fighting the battle to win the war. Curr Top Microbiol Immunol 2007;316: 167-192
59. Uematsu S, Akira S. Toll-like receptors and type I interferons. J Biol Chem 2007;282:15319-15323
60. Hritz I, Mandrekar P, Velayudham A, et al. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 2008;48:1224-1231
61. Zhao XJ, Dong Q, Bindas J, et al. TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J Immunol 2008;181:3049
62. Geisler F, Algül H, Paxian S, Schmid RM. Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro. Gastroenterology 2007;132:2489-2503 (Pubitemid 46890861)
63. Beraza N, Lüdde T, Assmus U, et al. Hepatocyte-specific IkK gamma/NEMO expression determines the degree of liver injury. Gastroenterology 2007;132:2504 (Pubitemid 46890863)
64. Mandrekar P, Jeliazkova V, Catalano D, Szabo G. Acute alcohol exposure exerts anti-inflammatory effects by inhibiting IkappaB kinase activity and p65 phosphorylation in human monocytes. J Immunol 2007;178:7686-7693 (Pubitemid 46898039)
65. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007;447:972-978 (Pubitemid 46975746)
66. Park PH, Huang H, McMullen MR, et al. Suppression of lipopolysaccharide- stimulated tumor necrosis factor-alpha production by adiponectin is mediated by transcriptional and post-transcriptional mechanisms. J Biol Chem 2008;283: 26850-26858
67. Gobejishvili L, Barve S, Joshi-Barve S, McClain CJ. Enhanced PDE4B expression augments LPS inducible TNF expression in ethanol primed monocytes: relevance to alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2008;295:G718-G724
68. McMullen MR, Pritchard MT, Wang Q, et al. Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. Gastroenterology 2005;128:2066-2076 (Pubitemid 40824714)
69. Thakur V, Pritchard MT, McMullen MR, Wang Q, Nagy LE. Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J Leukoc Biol 2006; 79:1348 (Pubitemid 44835570)
70. Lamlé J, Marhenke S, Borlak J, et al. Nuclear factor-erythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury. Gastroenterology 2008;134:1159-1168
71. Thimmulappa RK, Lee H, Rangasamy T, et al. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 2006; 116:984-995
72. Kohgo Y, Ohtake T, Ikuta K, et al. Dysregulation of systemic iron metabolism in alcoholic liver diseases. J Gastroenterol Hepatol 2008;23(Suppl 1):S78-S81
73. Suzuki M, Fujimoto Y, Suzuki Y, et al. Induction of transferrin receptor by ethanol in rat primary hepatocyte culture. Alcohol Clin Exp Res 2004;28(Suppl):98S-105S (Pubitemid 44139569)
74. Ohtake T, Saito H, Hosoki Y, et al. Hepcidin is down-regulated in alcohol loading. Alcohol Clin Exp Res 2007; 31(Suppl):S2-S8
75. Harrison-Findik DD, Klein E, Crist C, et al. Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol. Hepatology 2007;46:1979-1985
76. Tsukamoto H, Lin M, Ohata M, et al. Iron primes hepatic macrophages for NF-kappa B activation in alcoholic liver injury. Am J Physiol 1999;277:G1240-G1250 (Pubitemid 30046027)
77. Xiong S, She H, Zhang AS, et al. Hepatic macrophage iron aggravates experimental alcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2008;295:G512-G521
78. Duvigneau JC, Piskernik C, Haindl S, et al. A novel endotoxin-induced pathway: upregulation of heme oxygenase 1, accumulation of free iron, and free iron-mediated mitochondrial dysfunction. Lab Invest 2008;88:70-77
79. Szabo G, Mandrekar P. A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res 2009; 33:220-232
80. Muhanna N, Horani A, Doron S, Safadi R. Lymphocytehepatic stellate cell proximity suggests a direct interaction. Clin Exp Immunol 2007;148:338-347 (Pubitemid 46587597)
81. Winau F, Hegasy G, Weiskirchen R, et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007;26:117-129 (Pubitemid 46109346)
82. Brown LA, Cook RT, Jerrells TR, et al. Acute and chronic alcohol abuse modulate immunity. Alcohol Clin Exp Res 2006;30:1624-1631 (Pubitemid 44272753)
83. Gamble L, Mason CM, Nelson S. The effects of alcohol on immunity and bacterial infection in the lung. Med Mal Infect 2006;36:72-77 (Pubitemid 43294627)
84. Lau AH, Abe M, Thomson AW. Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo. J Leukoc Biol 2006;79:941-953 (Pubitemid 44835581)
85. Bedogni G, Miglioli L, Masutti F, et al. Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study. Am J Gastroenterol 2008;103:2248-2253
86. Ohnishi K, Matsuo S, Matsutani K, et al. Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers. Am J Gastroenterol 1996;91:1374-1379 (Pubitemid 26236373)
87. Zhang T, Li Y, Lai JP, et al. Alcohol potentiates hepatitis C virus replicon expression. Hepatology 2003;38:57-65 (Pubitemid 36775796)
88. Plumlee CR, Lazaro CA, Fausto N, Polyak SJ. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells. Virol J 2005;2:89 (Pubitemid 41831534)
89. Otani K, Korenaga M, Beard MR, et al. Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 2005;128(1):96-107 (Pubitemid 40039962)
90. Osna NA, White RL, Todero S, et al. Ethanol-induced oxidative stress suppresses generation of peptides for antigen presentation by hepatoma cells. Hepatology 2007;45:53-61 (Pubitemid 46144364)
91. Osna NA, White RL, Krutik VM, et al. Proteasome activation by hepatitis C core protein is reversed by ethanol-induced oxidative stress. Gastroenterology 2008;134:2144-2152 (Pubitemid 351783253)
92. Osna NA, Clemens DL, Donohue TM. Interferon gamma enhances proteasome activity in recombinant Hep G2 cells that express cytochrome P4502E1: modulation by ethanol. Biochem Pharmacol 2003;66:697-710 (Pubitemid 37011408)
93. Heinz R, Waltenbaugh C. Ethanol consumption modifies dendritic cell antigen presentation in mice. Alcohol Clin Exp Res 2007;31:1759-1771 (Pubitemid 47390040)
94. Dolganiuc A, Kodys K, Kopasz A. Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL-10 and IL-2 induction. Alcohol Clin Exp Res 2003;27:1023-1031 (Pubitemid 36759393)
95. Szabo G, Dolganiuc A, Mandrekar P, White B. Inhibition of antigen-presenting cell functions by alcohol: implications for hepatitis C virus infection. Alcohol 2004;33:241-249 (Pubitemid 41123667)
96. Aloman C, Gehring S, Wintermeyer P, Kuzushita N, Wands JR. Chronic ethanol consumption impairs cellular immune responses against HCV NS5 protein due to dendritic cell dysfunction. Gastroenterology 2007;132: 698-708 (Pubitemid 46274653)
97. Graham CS, Wells A, Edwards EM, et al. Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfection. J Infect Dis 2007;195:847-856 (Pubitemid 46363930)
98. Edsen-Moore MR, Fan J, Ness KJ, et al. Effects of chronic ethanol feeding on murine dendritic cell numbers, turnover rate, and dendropoiesis. Alcohol Clin Exp Res 2008;32: 1309-1320
99. Ness KJ, Fan J, Wilke WW, et al. Chronic ethanol consumption decreases murine Langerhans cell numbers and delays migration of Langerhans cells as well as dermal dendritic cells. Alcohol Clin Exp Res 2008;32:657-668
100. Lau AH, Thomson AW, Colvin BL. Chronic ethanol exposure affects in vivo migration of hepatic dendritic cells to secondary lymphoid tissue. Hum Immunol 2007;68:577-585 (Pubitemid 46920556)
101. Marcondes MC, Watry D, Zandonatti M, et al. Chronic alcohol consumption generates a vulnerable immune environment during early SIV infection in rhesus macaques. Alcohol Clin Exp Res 2008;32:1583-1592
102. Cao Q, Batey R, Pang G, Clancy R. Ethanol-altered liver-associated T cells mediate liver injury in rats administered Concanavalin A (Con A) or lipopolysaccharide (LPS). Alcohol Clin Exp Res 1999;23:1660-1667
103. Jaruga B, Hong F, Kim WH, et al. Chronic alcohol consumption accelerates liver injury in T cell-mediated hepatitis: alcohol dysregulation of NF-kappaB and STAT3 signaling pathways. Am J Physiol Gastrointest Liver Physiol 2004;287:G471-G479 (Pubitemid 38955268)
104. Pan HN, Sun R, Jaruga B, et al. Chronic ethanol consumption inhibits hepatic natural killer cell activity and accelerates murine cytomegalovirus- induced hepatitis. Alcohol Clin Exp Res 2006;30:1615-1623 (Pubitemid 44272752)
105. Jeong WI, Park O, Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 2008;134:248-258 (Pubitemid 350309310)
106. Meyerholz DK, Edsen-Moore M, McGill J. Chronic alcohol consumption increases the severity of murine influenza virus infections. J Immunol 2008;181:641-648
107. Jerrells TR, Pavlik JA, DeVasure J. Association of chronic alcohol consumption and increased susceptibility to and pathogenic effects of pulmonary infection with respiratory syncytial virus in mice. Alcohol 2007;41:357-369 (Pubitemid 47432743)
108. Zhang P, Bagby GJ, Happel KI, Summer WR, Nelson S. Pulmonary host defenses and alcohol. Front Biosci 2002;7: d1314-d1330
109. Happel KI, Rudner X, Quinton LJ. Acute alcohol intoxication suppresses the pulmonary ELR-negative CXC chemokine response to lipopolysaccharide. Alcohol 2007;41: 325-333 (Pubitemid 47418591)
110. Stoltz DA, Nelson S, Kolls JK, et al. In vitro ethanol suppresses alveolar macrophage TNF-alpha during simian immunodeficiency virus infection. Am J Respir Crit Care Med 2000;161:135-140
111. Willis MS, Klassen LW, Tuma DJ, Sorrell MF, Thiele GM. Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation. Alcohol Clin Exp Res 2002;26:94-106 (Pubitemid 34093516)
112. Vay D, Rigamonti C, Vidali M, et al. Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes. J Hepatol 2006;44:183 (Pubitemid 41772533)
113. Vidali M, Hietala J, Occhino G, et al. Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-alpha in heavy drinkers. Free Radic Biol Med 2008;45:306
114. Viitala K, Makkonen K, Israel Y, et al. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers. Alcohol Clin Exp Res 2000;24:1103-1109 (Pubitemid 30604332)
115. Latvala J, Hietala J, Koivisto H, et al. Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease. Am J Gastroenterol 2005;100:1303-1310 (Pubitemid 40904353)
116. Clot P, Albano E, Eliasson E, et al. Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholics. Gastroenterology 1996;111:206-216 (Pubitemid 26226901)
117. Mangia A, Margaglione M, Cascavilla I, et al. Anticardiolipin antibodies in patients with liver disease. Am J Gastroenterol 1999;94:2983-2987 (Pubitemid 29482769)
118. Cook RT, Schlueter AJ, Coleman RA. Thymocytes, pre-B cells, and organ changes in a mouse model of chronic ethanol ingestion - absence of subset-specific glucocorticoid- induced immune cell loss. Alcohol Clin Exp Res 2007; 31:1746-1758 (Pubitemid 47390039)